Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cellectis Nom. | 5 | 0 | 5 | 0 | €1.84 | €2.50 | 35.575% |
| Actinogen Ltd | 1 | 0 | 1 | 0 | €0.038 | - | - |
| EyePoint Pharmaceuticals Inc. | 22 | 1 | 3 | 0 | €7.73 | €27.83 | 259.853% |
| Zealand Pharma A/s | 1 | 0 | 1 | 0 | €127.80 | - | - |
| Codexis Inc. | 7 | 2 | 0 | 0 | €2.89 | €8.36 | 189.508% |
| Horizon Pharma plc | 4 | 0 | 0 | 0 | €110.40 | - | - |
| Intra-Cellular Therapies Inc. | 33 | 0 | 8 | 0 | €64.00 | €84.40 | 31.878% |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 2 | 0 | €37.40 | €85.51 | 128.640% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €2.97 | - | - |
| Affimed N.V. | 12 | 6 | 3 | 0 | €0.55 | €6.61 | 1095.570% |
| Abeona Therapeutics Inc. | 5 | 1 | 1 | 0 | €4.02 | €26.52 | 559.677% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €125.00 | €150.00 | 20.000% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €73.50 | - | - |
| Aclaris Therapeutics Inc | 4 | 0 | 3 | 0 | €1.09 | €2.75 | 153.456% |
| Canopy Growth Corp | 9 | 0 | 5 | 0 | €0.47 | €1.75 | 273.134% |
| Incyte Corp. | 12 | 3 | 0 | 1 | €53.18 | €78.05 | 46.760% |
| ProQR Therapeutics N.V. | 8 | 2 | 0 | 1 | €1.56 | €3.03 | 94.015% |
| Novartis AG ADR | 5 | 1 | 3 | 1 | €99.80 | €110.00 | 10.220% |
| PTC Therapeutics Inc. | 16 | 9 | 2 | 1 | €28.00 | €41.81 | 49.336% |
| Novavax Inc. | 4 | 1 | 0 | 1 | €11.67 | €17.59 | 50.772% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 1 | 1 | €39.00 | €43.87 | 12.485% |
| Evotec SE | 6 | 2 | 2 | 1 | €9.81 | €21.50 | 119.276% |
| Esperion Therapeutis.Inc. | 18 | 2 | 4 | 2 | €2.19 | €8.39 | 283.106% |
| Savara Inc. | 4 | 2 | 4 | 2 | €3.96 | €5.00 | 26.263% |
| G1 Therapeutics | 21 | 4 | 3 | 3 | €2.38 | €8.39 | 253.106% |